100 jili super ace
100 jili super ace
Haunting diary entries reveal the heartbreaking truth about John Wayne Gacy's forgotten victims
Make Christmas A Cozy Holiday: Yoolax Smart Blinds Offer Exclusive Discounts For Family GatheringsUkraine's Defence Minister agrees with US to deepen cooperation in cybersecurity
Firm using cryptography to keep AI accountable joins World via TFH acquisition
Craft, Suter score 18 as Miami (OH) knocks off Siena 70-58
TALLAHASSEE, Fla. (AP) — Luke Kromenhoek threw for 209 yards and tossed three touchdown passes as Florida State halted a six-game losing streak and routed Charleston Southern 41-7 on Saturday. Kromenhoek completed 13 of 20 passes in his first college start, including a 71-yard touchdown pass to Ja’Khi Douglas, as the Seminoles (2-9) won for the first time since Sept. 21. The true freshman also connected with Amaree Williams for a 4-yard TD and Hykeem Williams for a 10-yard TD. Florida State had the nation’s lowest scoring offense at 13.3 points. The Seminoles hadn’t scored more than 21 points or surpassed the 300-yard mark in 2024. But Florida State overwhelmed FCS Charleston Southern (1-11), accumulating 415 offensive yards. Kaleb Jackson completed 22 of 32 passes for 218 yards, including a 7-yard touchdown pass to Landon Sauers, and an interception for the Buccaneers. The takeaway Charleston Southern: While the Buccaneers found some success through the air, they couldn’t sustain drives and managed just 57 rushing yards on 29 carries. Florida State: The Seminoles picked up a season-best 176 rushing yards, scoring 17 points in the second quarter and 14 points in the third quarter to take control. Up next Charleston Southern’s season is over. Florida State plays host to Florida on Nov. 30. AP college football: https://apnews.com/hub/ap-top-25-college-football-poll and https://apnews.com/hub/college-football . Sign up for the AP’s college football newsletter: https://apnews.com/cfbtop25Home Oxygen Machines: Revolutionizing At-Home Health Care For Respiratory Patients And Improving Quality Of LifeMexico’S Shipping Platform ‘Airpost’ Expands Its Operation To The USA To Provide The Best International B2B Services
Transocean's Management Is Highly OptimisticPNC Financial Services Group Inc. Sells 1,037 Shares of Vanguard Utilities ETF (NYSEARCA:VPU)( MENAFN - GetNews) "Major players in metabolism assays market include Merck KGaA (Germany), Thermo Fisher (US), Abcam Plc. (UK), Agilent Technologies Inc. (US), and Kaneka Eurogentec S.A. (Belgium)."Browse 126 market data Tables and 38 Figures spread through 192 Pages and in-depth TOC on "Metabolism Assays Market by Product (Instruments, Assays Kits), Technology (Colorimetry, Fluorimetry, Spectrometry), Application (Diagnostics (Diabetes, Obesity), Research), End User (Hospitals, Diagnostic Laboratories), & Region - Global Forecast to 2028 Metabolism Assays Market in terms of revenue was estimated to be worth $1.4 billion in 2023 and is poised to reach $2.1 billion by 2028, growing at a CAGR of 7.8% from 2023 to 2028 according to a new report by MarketsandMarkets. The growth of this market is majorly driven by rising initiatives by government to promote metabolic & disease research, innovation in metabolism assays technology by integrating with wearable devices, increase in prevalence of metabolic disorders such as diabetes and obesity, and adoption of metabolism assays by fitness and sports industries. Download an Illustrative overview: Assay Kits and reagents segment is expected to account for the larger share in 2022. The metabolism assay market, by product, has been segmented into instruments & analyzers and assay kits & reagents. In 2022, the assay kits & reagents dominated the products market and are also estimated to grow at the highest CAGR during the forecast period. The large share is due to the recurrence of assay kits & reagents and easy availability. The diagnostic segment held the largest market share in the metabolism assay market. By application, the global metabolism assay market is broadly segmented into diagnostics and research. The diagnostics segment accounted for the larger share of the market in 2022. The diagnostics segment is also estimated to grow at the highest CAGR during the forecast period. The large share of this segment can be attributed to various factors, such as the growing number of obese population and the growing number of hospitals which are important end users for metabolism assays. North America dominates the global metabolism assay market. Based on the region, the metabolism assay market is segmented into North America, Europe, Asia Pacific, and Rest of the World. North American market is driven by well-established pharmaceutical and biotechnology industry, investments around drug discovery and toxicity testing. The Asia Pacific segment is projected to register the highest CAGR during the forecast period. The presence of a large population base coupled with large patient population and increasing rate of obesity are some of the major factors driving the growth of this regional market. Request Sample Pages: Metabolism Assays Market Dynamics: Drivers: 1. Increasing funding and investments in metabolic research Restraints: 1. High cost of metabolism assay analyzers Opportunities: 1. Integration with wearable devices Challenge: 1. Complexity of assay development Key Market Players: Major players in metabolism assays market include Merck KGaA (Germany), Thermo Fisher (US), Abcam Plc. (UK), Agilent Technologies Inc. (US), and Kaneka Eurogentec S.A. (Belgium). Get 10% Free Customization on this Report: MENAFN16122024003238003268ID1108999849 Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.
Friendly reminder |
The authenticity of this information has not been verified by this website and is for your reference only. Please do not reprint without permission. If authorized by this website, it should be used within the scope of authorization and marked with "Source: this website". |
Special attention |
Some articles on this website are reprinted from other media. The purpose of reprinting is to convey more industry information, which does not mean that this website agrees with their views and is responsible for their authenticity. Those who make comments on this website forum are responsible for their own content. This website has the right to reprint or quote on the website. The comments on the forum do not represent the views of this website. If you need to use the information provided by this website, please contact the original author. The copyright belongs to the original author. If you need to contact this website regarding copyright, please do so within 15 days. |